Jiecheng Medical
Minimally invasive heart valve replacement implant system
About Jiecheng Medical
Jiecheng Medical Technology, founded in 2009 in Suzhou, China, specializes in developing solutions for cardiovascular disease. The company's core offering is the J-Valve, a minimally invasive heart valve implant system designed for transapical and transvascular replacement of the aortic valve. This system, which includes the J-valve aortic valve bioprosthesis and the Ausper delivery system, aims to reduce patient trauma and recovery time compared to traditional open-heart surgery.
The company was established by Zhang Ji, a technical inventor and honorary professor at the Department of Cardiovascular Surgery, Peking University School of Medicine. The J-Valve system, which represents a significant medical device innovation with Chinese intellectual property, has received regulatory approvals, including from the FDA in April 2017 and China's National Medical Products Administration. It has also been used in procedures in Canada.
Jiecheng Medical operates in the competitive medical device market for cardiology. Before its acquisition, the company had secured funding from institutional investors such as 6 Dimensions Capital and Frontline BioVentures. In a significant milestone, Jiecheng Medical was acquired by Genesis MedTech on February 7, 2022, and now operates as a Genesis Medtech company.
Source: Dealroom company dataNews
Open roles
Jiecheng Medical in the Suzhou Shi ecosystem
The Jiecheng Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
6 Dimensions Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Jiecheng Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Jiecheng Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.